Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Diana Garofalo
Pfizer, Inc.
Poster(s):
(239) Background Incidence Rates of Guillain-Barre Syndrome in United States Older Adults at Risk of Respiratory Syncytial Virus in a Trial-Similar Real World Data Cohort
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST
(357) The Use of Background Incidence Rates to Support Vaccine Safety Monitoring: Challenges and Future Opportunities in the Framework of Beyond COVID Monitoring Excellence (BeCOME)
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST